Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
http://www.medicalnewstoday.com/articles/119637.php
A team of researchers at West Virginia University has shown that U.S. immigrants from India and Pakistan take on the habits of their adopted country, increasing their risks of prostate cancer among male immigrants and breast cancer among females.
----------------------------------------------
** CANCER / ONCOLOGY News **
Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
http://www.medicalnewstoday.com/articles/119637.php
A team of researchers at West Virginia University has shown that U.S. immigrants from India and Pakistan take on the habits of their adopted country, increasing their risks of prostate cancer among male immigrants and breast cancer among females.
Cancer - Curis Announces Dosing Of First Patient In Phase I Clinical Trial Of CUDC-101
http://www.medicalnewstoday.com/articles/119631.php
Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, announced that the first patient has been treated in a Phase I clinical trial of CUDC-101, a first-in-class small molecule drug candidate that has been designed as an inhibitor of epidermal growth factor receptor (EGFR), epidermal growth factor receptor 2 (Her2) and histone deacetylase (HDAC).
New Therapies Increasingly Being Used To Treat Liver Cancer
http://www.medicalnewstoday.com/articles/119629.php
According to Millennium Research Group's (MRG) US Markets for Transcatheter Embolization and Occlusion Devices 2008 report, embolization particle therapies such as radioembolization spheres are increasingly being used to treat liver cancer.
Morphotek(R), Inc. Expands Its Phase II Trial Site Selections In The European Union - Pancreatic Cancer Treatment
http://www.medicalnewstoday.com/articles/119627.php
Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, announced that it has opened clinical sites in the European Union (EU) as part of the company's MORAb-009 Phase II study.
By Altering Hundreds Of Genes, Black Raspberries Slow Cancer
http://www.medicalnewstoday.com/articles/119618.php
New research strongly suggests that a mix of preventative agents, such as those found in concentrated black raspberries, may more effectively inhibit cancer development than single agents aimed at shutting down a particular gene.
New England Journal Of Medicine Publishes Phase III Results Of VELCADE(R) (Bortezomib) For Injection In Previously Untreated Multiple Myeloma Patients
http://www.medicalnewstoday.com/articles/119611.php
Millennium: The Takeda Oncology Company announced the publication of results from the 682 patient, randomized, Phase III VISTA(1) trial in this week's edition of the New England Journal of Medicine.
A Proclamation By The President Of The United States Of America: National Ovarian Cancer Awareness Month, 2008
http://www.medicalnewstoday.com/articles/119599.php
During National Ovarian Cancer Awareness Month, we remember those whose lives have been affected by this deadly disease, and we underscore our commitment to battling ovarian cancer for the sake of women around the world.
Tough Journey For Families Of Children With Lymphoma
http://www.medicalnewstoday.com/articles/119568.php
A CQUniversity study has shown that families of children suffering from lymphoma face unique challenges that potentially make it more difficult to cope with the treatment experience than most.
Start Of Prolarix™ Phase 2 Study In Liver Cancer
http://www.medicalnewstoday.com/articles/119521.php
Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces the initiation of a phase 2a proof-of-concept study of Prolarix™, a targeted prodrug chemotherapy being developed for the treatment of primary liver cancer (hepatocellular carcinoma or "HCC").
Treatment For Cachexia - Ark's Vitor™ Commences Patient Enrolment Into Phase III Pilot Study
http://www.medicalnewstoday.com/articles/119520.php
Ark Therapeutics Group plc ("Ark" or the "Company") announces that enrolment of patients into its Phase III pilot study for VitorTM (Study 208) has commenced. VitorTM is Ark's product to treat cachexia (involuntary muscle wasting) associated with cancer.
ASTRO Selects Pediatric Oncologist As 2008 Honorary Member
http://www.medicalnewstoday.com/articles/119517.php
The American Society for Therapeutic Radiology and Oncology has selected renowned pediatric oncologist Audrey Evans, M.D., as its 2008 honorary member. Dr. Evans will be recognized during the Awards Ceremony held Tuesday, September 23, at 10:00 a.
Stopping Statins After Heart Attack Increases Risk Of Death
http://www.medicalnewstoday.com/articles/119507.php
Patients discontinuing statin medication following an acute myocardial infarction (AMI) increase their risk of dying over the next year, say researchers at McGill University and the McGill University Health Centre (MUHC).
Researchers Discover Atomic Bomb Effect Results In Adult-onset Thyroid Cancer
http://www.medicalnewstoday.com/articles/119346.php
Radiation from the atomic bomb blasts in Hiroshima and Nagasaki, Japan, in 1945, likely rearranged chromosomes in some survivors who later developed papillary thyroid cancer as adults, according to Japanese researchers.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Gleevec Receives FDA Priority Review As First Therapy To Reduce Recurrence Of Gastrointestinal Stromal Tumors After Surgery
http://www.medicalnewstoday.com/articles/119555.php
Novartis announced that Gleevec® (imatinib mesylate) tablets has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).
Bacteria Strain Linked To Stomach Ulcers Can Induce Cancer - Vanderbilt-Ingram Cancer Center Researchers Find New Assault Mechanism
http://www.medicalnewstoday.com/articles/119544.php
Researchers with Vanderbilt-Ingram Cancer Center have discovered one of the clues that may explain how a common stomach bacteria can trigger stomach cancer. <i>Helicobacter pylori </i>infects nearly 50 percent of the population and is the strongest known risk factor for gastric cancer.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Tough Journey For Families Of Children With Lymphoma
http://www.medicalnewstoday.com/articles/119568.php
A CQUniversity study has shown that families of children suffering from lymphoma face unique challenges that potentially make it more difficult to cope with the treatment experience than most.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Randomized Phase 2 Study Of IMC-A12 And IMC-1121B For Advanced Prostate Cancer Commences Patient Enrollment
http://www.medicalnewstoday.com/articles/119633.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial in patients with advanced prostate cancer randomized to treatment with either IMC-A12 or IMC-1121B plus mitoxantrone and prednisone has commenced patient enrollment.
Dana-Farber/Brigham And Women's Cancer Center Experts Webcast 10th Annual Patient Education Event On Prostate Cancer
http://www.medicalnewstoday.com/articles/119583.php
On September 10, 2008, at 6 p.m. E.T., leading prostate cancer specialists from Dana-Farber/Brigham and Women's Cancer Center will webcast their 10th Annual Symposium on Prostate Cancer, a patient education event featuring the newest advances in treatment, screening, and prevention of prostate cancer.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment